These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases. Dong DH; Zhang XF; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM; J Surg Oncol; 2019 Dec; 120(7):1071-1079. PubMed ID: 31571225 [TBL] [Abstract][Full Text] [Related]
4. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors. Tanaka M; Heckler M; Mihaljevic AL; Probst P; Klaiber U; Heger U; Schimmack S; Büchler MW; Hackert T Ann Surg Oncol; 2021 Mar; 28(3):1614-1624. PubMed ID: 32720049 [TBL] [Abstract][Full Text] [Related]
5. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors. Zhang Z; Wang F; Li Z; Ye Z; Zhuo Q; Xu W; Liu W; Liu M; Fan G; Qin Y; Zhang Y; Chen X; Yu X; Xu X; Ji S BMC Surg; 2022 May; 22(1):160. PubMed ID: 35538535 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis. Sun H; Zhou J; Liu K; Shen T; Wang X; Wang X Abdom Radiol (NY); 2019 Mar; 44(3):1000-1009. PubMed ID: 30539251 [TBL] [Abstract][Full Text] [Related]
7. Significance of lymph node metastasis in pancreatic neuroendocrine tumor. Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300 [TBL] [Abstract][Full Text] [Related]
8. Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review. Clarke CN; Ward E; Henry V; Nimmer K; Phan A; Evans DB Ann Surg Oncol; 2024 Aug; 31(8):4976-4985. PubMed ID: 38652199 [TBL] [Abstract][Full Text] [Related]
9. Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study. Kasai Y; Masui T; Nakakura EK; Nakano K; Sato A; Uchida Y; Yogo A; Nagai K; Anazawa T; Hope TA; Kim GE; Whitman J; Le BK; Takaori K; Bergsland EK; Hatano E; Uemoto S Pancreatology; 2022 Jan; 22(1):123-129. PubMed ID: 34736838 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study. Tan Q; Wang X; Li Y; Liu Y; Liu X; Ke N Front Endocrinol (Lausanne); 2022; 13():907415. PubMed ID: 35873006 [TBL] [Abstract][Full Text] [Related]
11. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors. Zhou B; Deng J; Chen L; Zheng S Sci Rep; 2017 Dec; 7(1):17506. PubMed ID: 29235538 [TBL] [Abstract][Full Text] [Related]
12. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141 [TBL] [Abstract][Full Text] [Related]
13. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management. Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET. Lombardi M; De Lio N; Funel N; Sardella C; Russo D; Urbani C; Rossi G; Campani D; Martino E; Marcocci C; Boggi U; Bogazzi F J Endocrinol Invest; 2015 Jun; 38(6):605-13. PubMed ID: 25501604 [TBL] [Abstract][Full Text] [Related]
15. Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival. Jutric Z; Grendar J; Hoen HM; Cho SW; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF Pancreas; 2017 Aug; 46(7):898-903. PubMed ID: 28697130 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter? Sallinen V; Haglund C; Seppänen H Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847 [TBL] [Abstract][Full Text] [Related]
17. Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer. Zhao BW; Chen YM; Jiang SS; Chen YB; Zhou ZW; Li YF PLoS One; 2015; 10(7):e0129531. PubMed ID: 26154617 [TBL] [Abstract][Full Text] [Related]
18. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907 [TBL] [Abstract][Full Text] [Related]
19. Indications for Surgical Resection in Low-Grade Pancreatic Neuroendocrine Tumors. Fitzgerald TL; Mosquera C; Vora HS; Vohra NA; Zervos EE Am Surg; 2016 Aug; 82(8):737-42. PubMed ID: 27657591 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors. Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]